Summit Therapeutics Management
Management criteria checks 2/4
Summit Therapeutics' CEO is Bob Duggan, appointed in Jul 2022, has a tenure of 2.33 years. directly owns 74.81% of the company’s shares, worth $11.52B. The average tenure of the management team and the board of directors is 2.3 years and 4.5 years respectively.
Key information
Bob Duggan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 74.8% |
| Management average tenure | 2.3yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry?
Nov 08
Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market
Oct 04Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial
Sep 19Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Sep 09Summit Therapeutics May Have Further Upside From Here
Aug 03Summit Therapeutics Stock: Plunging Despite A Win?
May 31Summit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer
May 06Summit Therapeutics: A Strategic Analysis Of Ivonescimab's Progress
Jan 30We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely
Dec 29Summit Therapeutics slips on plans to terminate study for lead candidate
Oct 04Summit Therapeutics: Developing Antibiotics Is A Noble Cause But The Company Is Wise To Expand Its Portfolio
Aug 17Summit Therapeutics GAAP EPS of -$0.17, revenue of $0.23M
Aug 11Summit to explore additional trial for its bacteria-induced colon infection drug
Jul 14Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation
Apr 29Summit Therapeutics - Disappointing Data But Not An Outright Failure
Dec 23Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator
Jun 22Summit Therapeutics to join Russell 3000 Index
Jun 08CEO
Bob Duggan (80 yo)
2.3yrs
Tenure
Mr. Robert W. Duggan, also known as Bob, had been an Interim Principal Financial Officer at Summit Therapeutics Inc. since July 02, 2021. He served as the Co-Chief Executive Officer at Summit Therapeutics...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & Executive Chairman | 2.3yrs | no data | 74.81% $ 11.5b | |
| Co-CEO, President & Director | 2.3yrs | US$20.56m | 4.85% $ 746.6m | |
| COO, CFO & Director | 1.1yrs | US$23.97m | 0.41% $ 63.1m | |
| Co-Founder | no data | no data | no data | |
| Chief Accounting Officer & Head of Finance | less than a year | no data | 0.018% $ 2.7m | |
| Head of Human Resources | 1.6yrs | no data | no data | |
| Head of Global Clinical Operations | 4.7yrs | no data | no data | |
| Chief Business & Strategy Officer | no data | no data | no data | |
| Head of Research | 3.4yrs | no data | no data | |
| Chief Biometrics Officer | 3.8yrs | no data | no data | |
| Chief Education & Brand Officer | 1.8yrs | no data | no data | |
| Head of Clinical Pharmacology & DMPK | 3.3yrs | no data | no data |
2.3yrs
Average Tenure
56yo
Average Age
Experienced Management: SMMT's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & Executive Chairman | 4.9yrs | no data | 74.81% $ 11.5b | |
| Co-CEO, President & Director | 4yrs | US$20.56m | 4.85% $ 746.6m | |
| COO, CFO & Director | 4.9yrs | US$23.97m | 0.41% $ 63.1m | |
| Co-Founder | no data | no data | no data | |
| Lead Independent Director | 3.1yrs | US$334.65k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory board | no data | no data | no data | |
| Member of Scientific Advisory board | no data | no data | no data | |
| Member of Scientific Advisory board | no data | no data | no data | |
| Member of Scientific Advisory board | no data | no data | no data |
4.5yrs
Average Tenure
65yo
Average Age
Experienced Board: SMMT's board of directors are considered experienced (4.5 years average tenure).